What We Do

We understand and shape public opinion ethically

Policy Advocacy

Market Entry Strategy for a Breakthrough Drug in India

The Challenge

CRS-the-challenge

A leading global pharmaceutical company planned to introduce a groundbreaking therapy in India, a market with immense potential but equally complex barriers. The client needed a policy advocacy roadmap that aligned with India’s unique healthcare ecosystem and addressed the dual challenge of policy risks and market readiness.

Our Solution

Phase 1

Decoding The Regulatory Landscape

Conducted a comprehensive scan of India’s healthcare policy environment. Analysed evolving drug approval processes, compliance requirements, and pricing frameworks. Delivered a clear picture of potential risks and opportunities for the therapy’s launch.

Phase 2

Undertaking A Policy Risk Assessment

Engaged expAnticipated regulatory and legislative bottlenecks. Identified policy levers and negotiation corridors that could influence approval and reimbursement outcomes. Developed scenario-based risk models to prepare the client for multiple policy outcomes.erts, customers and a cross section of key stakeholders including policy makers and regulators to explore shifts, expectations, and peer reviews to develop critical reputation drivers unique to India’s evolving financial ecosystem and the bank.

Phase 3

Creating Pathways for Stakeholder Alignment

Engaged with opinion leaders, policy makers, regulators, patient advocacy groups, and healthcare providers to understand access and affordability related issues as well regulatory pathways to craft a targeted advocacy and messaging plan to build alignment and mitigate risk.

The Result

CRS-the-result

The recommended pathway empowered the client to confidently navigate India’s complex healthcare policy landscape, overcome IPR disputes, affordability and access challenges to secure a successful product introduction.

Most importantly, patients in need gained access to an innovative life-saving therapy, reinforcing the company’s reputation as a trusted partner in India’s healthcare ecosystem and its commitment to affordable, accessible innovation.

Client Speak

It is amongst the best work that we have ever done for a new product launch of our global blockbuster drug

Sharada Adhikari SHARMA

Co-founder & Chief Science Officer

Sharada is the Co-Founder and Chief Science Officer of Astrum and leads the evidence-based consulting practice, translating complex data into WinningKnowledge that empowers clients to strengthen reputation, pre-empt reputation risks, and build competitive advantage. She has nearly two decades of expertise in market research, public policy research, crisis preparedness and social impact, she has led high-impact studies for multinational corporations, domestic enterprises, and leading political parties.

An Economics (Honours) graduate with a master’s degree in Economics from the Delhi School of Economics, Sharada also holds executive certifications in Public Policy Analysis from the London School of Economics, UK, and in Transformational Leadership from XLRI Jamshedpur.